Sana Alajmovic is Co-Founder and Chief Executive Officer of Sigrid Therapeutics AB, with successful experience in commercializing research and discovery by establishing partnerships with global top tier biopharmaceutical actors.
Sana Alajmovic has diverse experience in business development and management within the life science industry. Her previous positions include Head of Business Development for Drug Delivery at Nanologica, Business Development Manager at venture capital firm Serendipity Innovations Group and Project Manager for the Swedish-American Life Science Summit.
Before joining the life science industry, Sana was Managing Director for the venture capital firm Curitas within the private equity group Procuritas, Operations Manager for the charity foundation Chelha and Assistant Events & Marketing Manager at the Swedish-American Chamber of Commerce in New York.
